To require that United States supported clinical research that is conducted in sub-Saharan African countries be conducted in accordance with the most protective ethical standards regarding the use of human research subjects, and to prohibit the revocation or revision of intellectual property or competition laws or policies of sub-Saharan African countries that are designed to promote access to pharmaceuticals or other medical technologies.
Introduced in House
Introduced in House
Referred to the House Committee on International Relations.
Referred to the Subcommittee on International Economic Policy and Trade.
Referred to the Subcommittee on Africa.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line